Drug maker 'will make $21bn from treating cystic fibrosis' - The Guardian

Drug maker 'will make $21bn from treating cystic fibrosis'  The Guardian

A US company, which is refusing to drop its price for the life-changing cystic fibrosis drug Orkambi to make it affordable to NHS England, is set to make $21bn ...

from RSSMix.com Mix ID 8318969 https://ift.tt/33n2kXT